One more new one:
I find interesting as CBD has been reported to not bind to the CB1 yet it does modulate THC, this is how.
-SamS
http://www.ncbi.nlm.nih.gov/pubmed/26218440
Br J Pharmacol. 2015 Jul 27.
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor.
BACKGROUND AND PURPOSE:
Cannabidiol has been reported to act as an antagonist of cannabinoid agonists at type 1 cannabinoid receptors (CB1 ). We hypothesized that cannabidiol can inhibit cannabinoid agonist activity through negative allosteric modulation of CB1 .
I find interesting as CBD has been reported to not bind to the CB1 yet it does modulate THC, this is how.
-SamS
http://www.ncbi.nlm.nih.gov/pubmed/26218440
Br J Pharmacol. 2015 Jul 27.
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor.
BACKGROUND AND PURPOSE:
Cannabidiol has been reported to act as an antagonist of cannabinoid agonists at type 1 cannabinoid receptors (CB1 ). We hypothesized that cannabidiol can inhibit cannabinoid agonist activity through negative allosteric modulation of CB1 .
Last edited: